Archives: Agenda
FDA regulations in decentralized clinical trials
- An overview of the FDA’s latest guidelines and requirements for DCTs, highlighting key aspects such as the integration of digital health technologies, remote monitoring, and the adherence to Good Clinical Practice (GCP) principles, as well as ensuring innovative trials maintain the highest standards of safety, efficacy, and data integrity.
- Discussion of the FDA’s collaborative efforts with other regulatory bodies, promoting harmonized standards and facilitating global acceptance of DCT methodologies.
- Adhering to the FDA’s comprehensive regulatory requirements so sponsors can navigate the complexities of DCTs and contribute to the evolution of clinical trials and the accelerated development of innovative medical treatments
Improving clinical trial representation to increase access to trials
- Sharing best practices for recruiting and integrating populations that are not well represented in oncology trials
- Lessons from Advancing Inclusive Research Site Alliance collaborations
- What strategies that pharma/biotech and vendor companies can design and support to help sites reach a more diverse patient population
Strengthening the Sponsor-Site partnership: A path to a successful clinical trial: How collaboration and trust drive clinical trial success
- Understanding site processes and expectations to reduce delays in site initiation, activation, and screening for potential patients
- Championing collaborative sites for a streamlined trial
- Can we ever be appropriately equipped for adverse effects with off-site testing?
Afternoon refreshments and Apple Prize draw
Reserved for event sponsor
Transforming Patient Engagement in Clinical Trials: The Power of Gamification
| The success of clinical trials is critically dependent on consistent patient participation, yet challenges in engagement continue to extend study timelines and drive escalating costs. This educational session delves into gamification as an innovative and scientifically validated method to enhance patient retention and improve protocol adherence throughout the clinical research lifecycle.
Gamification, the strategic integration of behavioral science principles with interactive elements, motivates sustained patient engagement, directly addressing participant dropout and non-compliance. By deploying thoughtfully designed incentive structures and compelling engagement mechanisms, clinical research teams can notably elevate data quality, expedite study timelines, and reduce associated costs. This presentation explores three foundational dimensions of gamification within clinical research: its theoretical underpinnings, rationale for implementation, and demonstrated effectiveness in real-world trial environments. Attendees will benefit from: · Insight into psychological and behavioral drivers of sustained patient motivation · Practical strategies and best practices for incorporating gamified elements into clinical trials · Real-world case studies showcasing measurable improvements in participant retention and compliance |
Good Clinical Practice and Bioethics
• Put the theory into practice: from patient information to Informed Consent
• Real application of bioethics autonomy principle.
• Training in Good Clinical Practices: where we want to go
Chairperson’s closing remarks followed by Drinks Reception
PROOF-OF-CONCEPT: Bold Moves, Big Wins, and Lessons Learned
| Fast, Furious, or Never-Ending: Entertaining Case Studies on Accelerating and Unexpectedly Inflating Phase Ib/II Trial Timelines and Budgets. A Site Team Perspective |